Literature DB >> 27881404

Novel insights into fecal incontinence in men.

Yoav Mazor1,2, Michael Jones3, Alison Andrews4, John E Kellow4,2, Allison Malcolm4,2.   

Abstract

Fecal incontinence (FI) in men is common, yet data on sex differences in clinical features, physiology, and treatment are scarce. Our aim was to provide insights into FI in males compared with females. Prospectively collected data from 73 men and 596 women with FI in a tertiary referral center were analyzed. Anorectal physiology, clinical characteristics, and outcome of instrumented biofeedback (BF) were recorded. Thirty-one men with FI proceeded to BF and were matched with 62 age-matched women with FI who underwent BF. Men with FI had higher resting, squeeze, and cough anal sphincter pressures (P < 0.001) and were more able to hold a sustained squeeze compared with women (P = 0.04). Men with FI had higher rectal pressure and less inadequate rectal pressure on strain and higher sensory thresholds (P < 0.05). Men, but not women, with isolated soiling had higher anal resting and squeeze pressures compared with those with overt FI (P < 0.05). Men were less likely to undergo BF when offered compared with women. Baseline symptom severity did not differ between the groups. In men, the absence of an organic cause for the FI and the presence of overt FI, but not isolated soiling, were correlated with improvement in patient satisfaction following BF. The outcomes of 50% reduction in FI episodes, physician assessment, symptoms, and quality of life scores after BF all significantly improved in men similarly to women. We conclude that men, compared with women, with FI have unique clinical features and physiology and are less likely to have investigations and treatment despite successful outcome with BF. Future studies to customize treatment in males and determine barriers to therapy are warranted. NEW &amp; NOTEWORTHY: Fecal incontinence in men is common, yet data on sex differences in clinical features, physiology, and treatment are scarce. We provide evidence that men, compared with women, with fecal incontinence have unique clinical features and physiology and are less likely to have investigations and treatment despite successful outcome with anorectal biofeedback therapy.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  biofeedback; incontinence; physiology; sex

Mesh:

Year:  2016        PMID: 27881404     DOI: 10.1152/ajpgi.00362.2016

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  5 in total

1.  In vivo magnetofection: a novel approach for targeted topical delivery of nucleic acids for rectoanal motility disorders.

Authors:  Jagmohan Singh; Ipsita Mohanty; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-10-19       Impact factor: 4.052

Review 2.  Faecal incontinence in adults.

Authors:  Adil E Bharucha; Charles H Knowles; Isabelle Mack; Allison Malcolm; Nicholas Oblizajek; Satish Rao; S Mark Scott; Andrea Shin; Paul Enck
Journal:  Nat Rev Dis Primers       Date:  2022-08-10       Impact factor: 65.038

Review 3.  Review of the indications, methods, and clinical utility of anorectal manometry and the rectal balloon expulsion test.

Authors:  Adil E Bharucha; Guido Basilisco; Allison Malcolm; Tae Hee Lee; Matthew B Hoy; S Mark Scott; Satish S C Rao
Journal:  Neurogastroenterol Motil       Date:  2022-02-27       Impact factor: 3.960

4.  Optimizing techniques for measuring anal resting and squeeze pressures with high-resolution manometry.

Authors:  Nicholas R Oblizajek; Brototo Deb; Shivabalan Shiva Kathavarayan Ramu; Zainali Chunawala; Kelly Feuerhak; Kent R Bailey; Adil E Bharucha
Journal:  Neurogastroenterol Motil       Date:  2022-04-25       Impact factor: 3.960

5.  Downregulation of thromboxane A2 and angiotensin II type 1 receptors associated with aging-related decrease in internal anal sphincter tone.

Authors:  Ipsita Mohanty; Jagmohan Singh; Satish Rattan
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.